Past Accomplishments and Ongoing Initiatives
We filed a provisional patent for a reusable 4-layer all-natural cotton / silk general-purpose face mask that creates a self-sustaining tribo-electric gram-positive charge that is intended to neutralize gram-negative microbes. The video at left details the technology and scientific underpinnings of the face covering. We had biological laboratory testing of the Stay Safer face covering performed but delayed conducting filtration and leakage testing pending updates to the ASTM Barrier Face Covering standard's requirements.
2021 - 2022
Until recently, there existed no examination of the relative cost of novel multi-drug anticancer treatments vs. traditional therapy options, or study as to how knowledge about comparative treatment costs at the point-of-care could be leveraged by doctors, health systems, and payers.
Our soon to be published March 2022 research study challenges common misconceptions about combination cancer treatments, their cost and value. It provides payers, providers and patients alike with important insight as to how they can better select medications (that are likely to be more effective) and avoid enormously expensive, low-clinical-value drugs that are wasteful.
Gaining Control of Combination Cancer Treatment Risk by Incorporating Cost and Value Data into the Drug Selection Process at the Point-of-Care shows why there is no longer a reason to continue the practice of uninformed, high-stakes oncology prescribing given the emergence of Healthcare AI that can guide drug selection and drive value for payers and patients alike. It is available for download by clicking on the image above or on MedRxiv here.